SCHEMBL4839611

SCHEMBL4839611

COC(=O)C1(c2ccc(OCCN)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
TSHR P16473 1/20 0.49
ALDH1A1 P00352 4/20 0.44
LMNA P02545 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HRH3 Q9Y5N1 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
LTA4H P09960 1/20 0.39
PLA2G2A P14555 1/20 0.39
SPHK1 Q9NYA1 2/20 0.39
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
RAB9A P51151 1/20 0.38
ESR1 P03372 1/20 0.38
CYP19A1 P11511 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1465605 0.84 L3MBTL1 (0.54) MEN1KMT2ATSHRALDH1A1LMNA
SCHEMBL837139 0.79 ALDH1A1 (0.55) MEN1KMT2AALDH1A1LMNAL3MBTL1
SCHEMBL1465706 0.79 MEN1 (0.43) MEN1KMT2ATSHRALDH1A1L3MBTL1
SCHEMBL25432525 0.78 PARP15 (0.50) MEN1KMT2ATSHRHRH3
SCHEMBL25382378 0.78 CA12 (0.44) MEN1KMT2ATSHRALDH1A1SMN1; SMN2
SCHEMBL20755014 0.77 NPC1 (0.55) ALDH1A1LMNASMN1; SMN2LTA4HRAB9A
SCHEMBL23163757 0.76 MEN1 (0.52) MEN1KMT2ATSHRMAPTHRH3
SCHEMBL1465475 0.76 POLB (0.42) MEN1KMT2AALDH1A1LMNAL3MBTL1
SCHEMBL12989336 0.75 ALDH1A1 (0.42) MEN1KMT2ATSHRALDH1A1MAPT
SCHEMBL15601973 0.75 KMT2A (0.42) MEN1KMT2ATSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102746214-A Novel indoline compounds FOURNIER LAB SA 2012-10-24 CN disclosed
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed
CN-101184731-A Indoline compounds FOURNIER LAB SA (FR) 2008-05-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 MEN1 2712/4885KMT2A 1435/4885TSHR 681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.